Health Care Costs

Latest California Healthline Stories

Podcast: KHN’s ‘What The Health?’ Rocky Road Ahead In Congress For Insurance Market Bills

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the problems that are making congressional efforts to pass legislation to stabilize the individual insurance market a long shot.

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

Bipartisan Senate Budget Deal Boosts Health Programs

The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.

Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?

In this Facebook Live chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.